Pureos Bioventures, one of our partners, announced yesterday the closing of their first fund, at USD 170 million! Great news for the broader European biotech ecosystem. We are extremely proud to be working with them to help fuel the next wave of innovative biotech companies.
“We are extremely pleased with the successful closing of our first fund. This would not have been possible without the trust and support of our investors to whom we are tremendously thankful. With the entrusted monies, we want to build and support great teams developing innovative therapeutics for devastating diseases that make a true difference for patients.” said the founding partners Klaus Breiner, Dominik Escher, and Martin Münchbach.
See the full press release here.